Sort
46,585 grants matching “heart failure”
Development of a Mucosal Nanoemulsion-Adjuvanted RSV Vaccine using Recombinant Pre-Fusion F Protein
$891,695Kevin Trabbic · Bluewillow Biologics, Inc. · R44 · FY2024 · AI
Overdose Risk Management and Compensation in the Era of Naloxone
$890,476Alexander S Bennett · New York University · R01 · FY2021 · DA
Translational Development of Glial Growth Factor 2 (GGF2) for the Treatment of St
$889,977Anthony O Caggiano · Acorda Therapeutics, Inc. · U01 · FY2016 · NS
(1/2) Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)
$889,542Dennis M. McNamara · University Of Pittsburgh At Pittsburgh · UH3 · FY2022 · HL
Exploration of novel block-and-lock agents alone and in combination for HIV remission in humanized mice
$889,277Susana T Valente · University Of Florida · R01 · FY2024 · AI
True 4DCT for Quantifying LV Dyssynchrony and Function for Targeting LV Lead Location in CRT
$888,993Elliot R McVeigh · University Of California, San Diego · R01 · FY2019 · HL
Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus
$888,853Gordon H Williams · Brigham And Women'S Hospital · R01 · FY2009 · HL
Women's Health Study: Continued Follow-Up
$888,766Brigham And Women'S Hospital · R01 · FY2005 · HL
Mapping the Progression to HFpEF in the Elderly through Longitudinal Changes in Cardiac Function
$888,382Amil M Shah · Brigham And Women'S Hospital · R01 · FY2017 · HL
1/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT)
$887,209Keith R. McCrae · Cleveland Clinic Lerner Com-Cwru · UH3 · FY2022 · HL
ECHOCARDIOGRAPHY READING CENTER
$887,199Scott David Solomon · Brigham And Women'S Hospital · N01 · FY2013 · HL
A Phase 2a Clinical Study of a Cardiac Hormone for the Outpatient Treatment of Worsening Heart Failure
$887,140Lawrence Mahan · Madeleine Pharmaceuticals, Inc. · R44 · FY2020 · HL
Engineered tissue-based, high-throughput compound profiling
$887,123Victoriya Aleksandrovna Rufanova · Invivo Sciences, Llc. · R44 · FY2010 · GM
Engineered tissue-based, high-throughput compound profiling
$886,967Tetsuro Wakatsuki · Invivosciences, Inc. · R44 · FY2012 · GM
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
$886,843Anand Vaidya · Brigham And Women'S Hospital · R01 · FY2020 · HL
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti - 2
$885,886Margaret Leighton McNairy · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · HL
Precise Minimally InvasiveTreatment of VT Using Non-invasive Mapping.
$885,868Dwight Meglan · Heartlander Surgical, Inc. · R44 · FY2020 · HL
Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome
$885,825Nadir Yehya · Children'S Hosp Of Philadelphia · R01 · FY2019 · HL
ShRNA-Based Targeting of mAKAPò in Heart Failure
$885,032Federico Cividini · Cardiac Rsk3 Inhibitors, Llc · R44 · FY2022 · HL
Single cell, whole genome analysis of the aging human cardiomyocyte
$884,984Sangita Choudhury · Boston Children'S Hospital · R01 · FY2021 · HL
Development of a Total Artificial Lung
$884,809University Of Michigan At Ann Arbor · R01 · FY2002 · HL
Development and Commercialization of a weight monitoring platform for wheelchair users
$884,788Sami Shaaban · Nurelm E-Business Software · R44 · FY2025 · HD
Deciphering how 3D genome organization orchestrates cardiac cellular identity
$884,375Rajan Jain · University Of Pennsylvania · R35 · FY2023 · HL
Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease: A Multi-site Randomized Clinical Trial
$884,371Lipika Samal · Brigham And Women'S Hospital · R01 · FY2025 · DK
Role of the giant protein titin in cardiac health and disease
$884,369Henk L. Granzier · University Of Arizona · R35 · FY2019 · HL